Diabetes in Society

English

Diabetes and the World Health Organization

The aim of the World Health Organization (WHO) is the achievement of the highest possible level of health for all the world's people. From its global headquarters in Geneva and its Regional Offices, it assists national governments achieve this aim by setting international norms and standards, and providing leadership and technical support. WHO has substantial influence and prestige and has several major accomplishments to its credit, most notably the global eradication of smallpox in 1979, and major reductions in the burden of polio, leprosy, river blindness and tuberculosis.

WDF and diabetes care in Tanzania: making a difference

The World Diabetes Foundation (WDF) is dedicated to supporting prevention and management of diabetes in the developing world. Accordingly it funds sustainable projects in education, capacity building, and distribution and procurement of essential medical supplies. WDF creates partnerships and acts as a catalyst to help others

Better product information: is direct advertising the answer?

In the last few years, there has been an important but little-publicized

The cost of kidney disease in India: one person's story

India is fast-becoming the diabetes capital of the world. More than 35.5 million people in India now have diabetes. This figure is likely to rise to 57 million by 2025. This increase, principally in people with Type 2 diabetes, is bringing with it a sharp growth in diabetic complications, including eye disease (retinopathy) and kidney disease (nephropathy). In this report, Ambady Ramachandran describes the costs of diabetes and kidney disease to a person in India

The costs of kidney disease

Existing and recent health-care interventions have the potential to reduce the economic impact of diabetes complications, including kidney (renal) disease. In this article, Thomas Songer provides a brief overview of current understanding regarding the costs related to kidney disease.

Diabetic kidney disease in disadvantaged people

A rising frequency of diabetic kidney disease worldwide is disproportionately affecting disadvantaged people. Among the hardest hit are people in the poorest countries, which lack the public health infrastructure to address the epidemic using treatments widely available in the developed world. In this article, Robert Nelson examines the frequency of diabetic kidney disease in various parts of the world, explores some reasons why disadvantaged populations may be particularly vulnerable to this complication of diabetes, and describes how health-care providers may successfully

Diabetes education and empowerment: a role for youth

In 1996, American Youth Understanding Diabetes Abroad (AYUDA) was set up by two teenagers after they had witnessed the economic and emotional hardships faced by José Gabriel and other young people living with diabetes in Latin America.They envisioned a youth-led organization that would educate young people with diabetes about diabetes issues, and help empower them to work effectively for positive change. AYUDA is now a growing organization, which campaigns to raise diabetes awareness and promote sustainable development for diabetes communities throughout the world.

Discrimination on high: flying on insulin

For the safety of the passengers and crew of an aeroplane, it is imperative that an airline pilot maintain a high level of fitness. There are a number of medical conditions which, once diagnosed, may prevent a pilot being allowed to fly a plane. If they can be stabilized, some conditions may allow a return to work. Other conditions are classed as 'non-medically certifiable'. Upon diagnosis of a non-medically certifiable condition, a pilot's medical certificate will be denied, and if already issued, it will be revoked.

Why developing countries need access to cheap treatments for diabetes

There is still a widespread misconception that non-communicable diseases such as diabetes are not relevant to poor people in developing countries. For these people, medicines for the treatment of such conditions are regarded almost as a luxury. Scientific evidence testifies to the contrary. Non-communicable diseases such as diabetes are escalating in developing countries. This is giving rise to severe economic as well as human consequences. An effective public health strategy for poor countries requires continued access to low-cost, high-quality generic medicines.

IDF child sponsorship: life for a child with diabetes

For a family in a developing country, having a child diagnosed with diabetes can bring an overwhelming financial burden, and often ends in heartbreak. The IDF Child Sponsorship Programme, Life for a child with diabetes was established to help meet the medical needs of children with diabetes in developing countries, their families, and those who care for them. The Programme provides support to children's diabetes centres in developing countries, so that best practice care for that country can be provided to children from even the poorest situations.

Pages